Relmada Therapeutics RLMD
NASDAQ RLMD
$3.27 -0.02 (-0.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Net Shares Issued and Repurchased (2012 - 2026)

Updated

Analysis

Relmada Therapeutics (RLMD) Net Shares Issued and Repurchased (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -966.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -9.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Relmada Therapeutics 348.81 Mn -209.78 Mn - -6.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.35 Mn
Mar 31, 2026 156.64 Mn
Mar 31, 2024 246,747.00
Dec 31, 2022 36,251.00
Sep 30, 2022 619,092.00
Jun 30, 2022 14.09 Mn
Mar 31, 2022 29.95 Mn
Dec 31, 2021 161.23 Mn
Sep 30, 2021 -42,014.00
Jun 30, 2021 21.53 Mn
Mar 31, 2021 1.93 Mn
Dec 31, 2020 944,153.00
Sep 30, 2020 1.63 Mn
Jun 30, 2020 22.89 Mn
Mar 31, 2020 3.12 Mn
Sep 30, 2019 1.28 Mn
Jun 30, 2019 10.86 Mn
Mar 31, 2019 1.73 Mn
Dec 31, 2018 3.90 Mn
Sep 30, 2018 404,500.00
API Access

Relmada Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=RLMD&period=max&api_key=YOUR_API_KEY